QT
MRSN

Quantbot Technologies’s Mersana Therapeutics MRSN Stock Holding History

Quantbot Technologies’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-438
Closed -$25.4K – 1794
2023
Q4 		$25.4K Buy
+438
New +$17.6K ﹤0.01% 1414
2022
Q3 		– Sell
-38
Closed -$4K – 1902
2022
Q2 		$4K Sell
38
-336
-90% -$31.6K ﹤0.01% 1595
2022
Q1 		$37K Buy
+374
New +$43.7K ﹤0.01% 1256
2021
Q3 		– Sell
-648
Closed -$219K – 1754
2021
Q2 		$219K Buy
+648
New +$245K 0.02% 725
2020
Q4 		– Sell
-20
Closed -$9K – 1537
2020
Q3 		$9K Buy
+20
New +$10.1K ﹤0.01% 1130

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return